Earnings Ahead

ALNY - Alnylam Pharmaceuticals, Inc.

188.8 -2.55 -1.33

Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

About

Profile


Headquarters

Cambridge, Massachusetts, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

ALNY



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Alnylam posts Q4 topline miss; pushes back key data readout
  • Alnylam Pharmaceuticals Non-GAAP EPS of -$0.77 in-line, revenue of $439.72M misses by $2.58M
  • Alnylam Pharmaceuticals Q4 2023 Earnings Preview
  • Investors growing more bullish on SMID cap biotech stocks
  • Regeneron eyes Wegovy combo to improve quality of weight loss
  • Alnylam reports preliminary Q4 global net product revenues
  • U.S. strong buy ideas for the next 12 months – according to Citi
  • Biotechs post record gains in November amid improving outlook
  • Alnylam reports positive Phase 2 data for hypertension drug
  • Alnylam Pharmaceuticals beats Q3 top and bottom line estimates; updates FY23 outlook
  • Alnylam Pharmaceuticals Q3 2023 Earnings Preview
  • Alnylam downgraded at Oppenheimer ahead of key data readout
  • Alnylam sends Arbutus lower after FDA snub for amyloidosis drug
  • Alnylam U.S. label expansion for amyloidosis drug denied
  • Ionis, AbbVie, Alnylam draw bullish views at Raymond James
  • Citi says concerns over FDA approval of Alnylam drug are "overdone"
  • Alnylam stock falls after FDA panel questions drug's effectiveness
  • Alnylam wins FDA panel backing additional Onpattro indications
  • Alnylam stock trading halted as FDA AdCom meets on amyloidosis drug
  • Alnylam amyloidosis drug led to “small” benefits in Phase 3 trial: FDA
PEERS
/XLV

XLV

Earnings History

Date EPS / Forecast Revenue / Forecast
February 10, 2022 -2.16 / -1.56 258.54M / 232.49M Beat!
October 28, 2021 -1.72 / -1.54 187.63M / 218.72M
August 3, 2021 -1.61 / -1.61 220.55M / 192.05M Beat!
April 29, 2021 -1.71 / -1.75 177.57M / 168.5M Beat!
February 11, 2021 -2.09 / -1.78 163.56M / 146.64M Beat!
November 5, 2020 -2.18 / -1.63 125.85M / 119.05M Beat!
August 6, 2020 -1.56 / -1.72 103.96M / 98.76M Beat!
May 6, 2020 -1.62 / -1.89 99.48M / 91.74M Beat!
February 6, 2020 -2.47 / -2.21 71.68M / 71.6M Beat!
October 31, 2019 -1.92 / -2.07 70.06M / 57.17M Beat!
Date Price Open High Low Vol Change
Dec 2 464.93 453.9
472.48
453.01
1.2M 2.28%
Dec 1 454.56 450
462.93
448.27
1.1M 0.74%
Nov 28 451.23 448.18
455.76
444.43
564K 1.37%
Nov 26 445.12 432.87
447.69
430.27
908K 3.56%
Nov 25 429.8 436.84
441.82
428.57
1.0M -1.02%
 
Nov 24 434.23 439.46
444.67
420.3
1.8M -0.49%
Nov 21 436.38 448.23
449.53
433.5
1.3M -2.11%
Nov 20 445.79 463.32
467.73
445.34
788K -3.25%
Nov 19 460.76 462.27
465.32
456.9
894K -0.33%
Nov 18 462.3 458.15
469.11
456.27
669K 0.38%
Nov 17 460.54 449
463.92
449
962K 2.53%
Nov 14 449.16 453.87
461.96
448.28
969K -1.06%
Nov 13 453.97 450.67
456.14
447.12
799K 0.27%
Nov 12 452.74 450.63
459.27
446.71
938K 0.17%
Nov 11 451.95 443.53
455.2
441.21
982K 2.32%
Nov 10 441.7 445
449.68
440.93
739K -0.23%
Nov 7 442.7 437.81
443.69
430.83
823K 0.50%
Nov 6 440.49 431.78
445.5
429
701K 1.36%
Nov 5 434.56 422.11
438.53
417
975K 2.62%
Nov 4 423.47 429.9
431.5
421.83
1.2M -2.44%
Nov 3 434.07 454.58
457.26
429.6
1.6M -4.82%
Oct 31 456.04 449
459.77
441.22
1.8M 1.44%
Oct 30 449.56 450
472.36
436.51
2.3M -6.65%
Oct 29 481.59 475.19
482.73
467.09
1.4M 1.19%
Oct 28 475.91 476.5
484.61
473.29
836K -0.56%
Oct 27 478.58 465.56
485.36
465.55
1.2M 3.27%
Oct 24 463.43 468.68
469.29
459.38
771K -0.12%
Oct 23 464 464.71
468.86
456.9
683K -0.19%
Oct 22 464.9 477.66
480.53
461.21
950K -1.92%
Oct 21 474 488.42
490.05
471.4
826K -3.51%
Oct 20 491.22 476.82
495.55
476.82
950K 1.98%
Oct 17 481.67 481.65
492.62
476.44
1.0M 0.12%
Oct 16 481.07 474.39
488.39
470.46
965K 2.30%
Oct 15 470.27 469.19
485.28
467.5
1.5M 0.19%
Oct 14 469.36 462.13
479.69
457.73
1.4M 0.95%
Oct 13 464.95 456.13
473.65
453.83
1.6M 0.98%
Oct 10 460.46 460.28
460.6
451
937K 0.77%
Oct 9 456.95 451
459.57
448.83
1.1M 1.39%
Oct 8 450.68 464.46
464.46
449.72
930K -1.94%
Oct 7 459.58 456.94
462.63
448.95
792K 1.68%
Oct 6 452 458.69
458.69
449.92
919K -0.95%
Oct 3 456.35 465.01
465.01
448.47
969K -1.01%
Oct 2 460.99 457.64
461.53
446.18
1.3M 0.07%
Oct 1 460.65 456
467.42
453.31
1.4M 1.02%
Sep 30 456 445.22
459.3
445.22
1.4M 1.90%
Sep 29 447.49 448
451.63
446.3
719K 0.24%
Sep 26 446.4 453.05
453.05
442.51
813K -0.71%
Sep 25 449.58 457.03
459
446.42
685K -1.92%
Sep 24 458.37 454.35
462.69
450.97
976K 0.87%
Sep 23 454.41 452.83
457.47
450.5
1.0M -0.98%
Sep 22 458.92 453.56
462.88
450.23
972K 1.18%
Sep 19 453.56 457.68
457.68
450.72
1.7M 0.31%
Sep 18 452.17 453.99
456.94
443.75
1.1M 0.10%
Sep 17 451.73 455.76
463.88
450.7
1.4M -2.06%
Sep 16 461.24 465.14
467.28
457.99
774K 0.02%
Sep 15 461.14 464.8
466.24
454.51
910K -1.02%
Sep 12 465.89 468.29
475.69
465.48
631K -0.57%
Sep 11 468.58 474.34
474.34
465.16
1.0M -0.16%
Sep 10 469.31 478.5
480.05
461.47
1.8M -2.66%
Sep 9 482.13 461.11
484.21
455.3
3.2M 0%